Carnegie Mellon University

Startup to Develop PNA Technology for Gene Editing

September 13, 2019

Startup to Develop PNA Technology for Gene Editing

Jocelyn Duffy
  • Associate Dean for Communications, MCS

Truecode Gene Repair has licensed peptide nucleic acid (PNA) technology developed by Chemistry Professor Danith Ly to develop new gene editing therapies. Ly, who directs the Institute for Biomedical Design and Discovery at Carnegie Mellon University, and his collaborators at Yale University did the foundational work developing PNAs for gene editing, having used the technology to cure mice of a genetic blood disorder. Truecode is the second company to license Ly's PNA technology from Carnegie Mellon. Neubase is using PNAs to develop therapies that silence and alter gene expression.

Read more in Chemical and Engineering News: https://cen.acs.org/business/start-ups/Gene-editing-startup-Trucode-raised/97/i36